Anti-CD4 monoclonal antibody fragment
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-CD4 monoclonal antibody fragment, covering 2008-05-28 to 2008-05-28. Get the full timeline:
Most recent: Clinical Trial Update: The Use of Anti-CD4 Monoclonal Antibody (mAb)-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis [Phase 1, Phase 2]